Ideal Candidates BMI 27 with central adiposity, slow recovery, or age-related GH decline Athletes in calorie-cut phases seeking to protect lean mass Individuals battling insomnia linked to low nocturnal GH Not pregnant, breastfeeding, or with active malignancy Unsure you qualify
Current Opinion in Behavioral Sciences , 9, 66-70
[PMID: 9637272] PubMed record related to this compound for laboratory literature review
Healthier Appearance The antioxidant effects contribute to a refreshed and rejuvenated look
0.4% at Site-4), underscoring the need to use local epidemiology to guide empiric therapy
A, Food intake 1 h after an acute ICV injection of GLP-1 (3 nmol), GLP-1 plus exendin-(939) (30 nmol), OXM (3 nmol), OXM and exendin- (939) (30 nmol), or exendin- (939) alone (30 nmol)